Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.63

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.8

Views

Views
September 20257
October 20250
November 20250
December 20250
January 20261
February 20260
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Singapore1
 

Top cities views

Views
Dallas6